<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Virulence</journal-id>
      <journal-id journal-id-type="iso-abbrev">Virulence</journal-id>
      <journal-id journal-id-type="publisher-id">VIRU</journal-id>
      <journal-title-group>
        <journal-title>Virulence</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2150-5594</issn>
      <issn pub-type="epub">2150-5608</issn>
      <publisher>
        <publisher-name>Landes Bioscience</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23076275</article-id>
      <article-id pub-id-type="pmc">3524159</article-id>
      <article-id pub-id-type="publisher-id">2012VIRULENCE0107R</article-id>
      <article-id pub-id-type="doi">10.4161/viru.22090</article-id>
      <article-id pub-id-type="pii">22090</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Alteration of GI symptoms in a cow with Johne disease by the dietary organosulfur, 2-mercaptoethanol</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Click</surname>
            <given-names>Robert E.</given-names>
          </name>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>Correspondence to: Robert E. Click, Email: <email xlink:href="mbclicker@msn.com">mbclicker@msn.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>01</day>
        <month>10</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>01</day>
        <month>10</month>
        <year>2012</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <volume>3</volume>
      <issue>6</issue>
      <fpage>543</fpage>
      <lpage>545</lpage>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2012 Landes Bioscience</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Sub-phenotypes of inflammatory bowel disease (IBD)&#x2014;Crohn disease, ulcerative colitis and some cases of irritable bowel syndrome&#x2014;are generally considered a consequence of gastrointestinal inflammation of unknown etiology. Conventional therapy and more recently biologic agents, all with varying degrees of drawbacks, have resulted in improved control of these diseases. However, as the incidence and prevalence continue to rise, needs for prevention, permanent remission and cures remain unmet, plus there still remain needs for improved control of symptoms, such as pain and diarrhea. The case report herein describes a serendipitous, novel means for curtailing these symptoms associated with a bovine gastrointestinal disease that may have applicability for patients with diseases characterized by abdominal-visceral pain and diarrhea.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>2-mercaptoethanol</kwd>
        <kwd>dietary organosulfurs</kwd>
        <kwd>bovine Johne disease</kwd>
        <kwd><italic>Mycobacterium avium</italic> ssp <italic>paratuberculosis</italic></kwd>
        <kwd>MAP</kwd>
        <kwd>IBS</kwd>
        <kwd>ulcerative colitis</kwd>
        <kwd>Crohn disease</kwd>
        <kwd>diarrhea</kwd>
        <kwd>pain</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>The case report herein describes a serendipitous, novel means of curtailing pain and diarrhea associated with a bovine gastrointestinal disease (Johne disease) that may potentially be beneficial for relieving abdominal-visceral pain and diarrhea in patients with gastrointestinal diseases.</p>
    <p>Johne disease&#x2014;a world-wide disease primarily in ruminants, most prevalent in cattle, sheep and goats, but even in wildlife&#x2014;has many manifestations in common with the human IBD, Crohn disease (CD),<xref ref-type="bibr" rid="R1"><sup>1</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R4"><sup>4</sup></xref> including pain and debilitating diarrhea (in cattle). As with CD, there are no preventive/curative therapies for Johne disease outside a probiotic Dietzia therapy.<xref ref-type="bibr" rid="R5"><sup>5</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R7"><sup>7</sup></xref> The etiologic agent of Johne disease is <italic>Mycobacterium avium</italic> subspecies <italic>paratuberculosis</italic> (MAP). Natural exposure of cattle to MAP, which usually results in clinical disease at &gt; 2 y of age, occurs primarily in utero and/or by oral ingestion of MAP by neonates.<xref ref-type="bibr" rid="R8"><sup>8</sup></xref> For disease to be manifested, infection with MAP is followed by intestinal inflammation.</p>
    <p>Interestingly, humans are also systemically infected with MAP. However, the incidence of infection in the &#x201C;normal&#x201D; population is lower than in those with Crohn disease,<xref ref-type="bibr" rid="R9"><sup>9</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R13"><sup>13</sup></xref> ulcerative colitis<xref ref-type="bibr" rid="R13"><sup>13</sup></xref> and irritable bowel syndrome,<xref ref-type="bibr" rid="R13"><sup>13</sup></xref> three diseases characterized in whole or part by gastrointestinal pain and diarrhea. Unfortunately, the consequences&#x2014;cause, perpetuate, bystander&#x2014;of such associations are highly controversial and remain to be unequivocally clarified.</p>
    <p>The initial investigations on alteration of cellular processes by 2-Me originated in this laboratory when various murine immunological reactivities in vitro were found to be dramatically enhanced by, or dependent upon, sulfhydryl compounds&#x2014;of those studied, the most potent was 2-Me.<xref ref-type="bibr" rid="R14"><sup>14</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R17"><sup>17</sup></xref> Subsequently, a number of in situ processes/diseases were found to also be altered by 2-Me. For example, 2-Me (1) reversed the loss of immune functions associated with aging,<xref ref-type="bibr" rid="R18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R19"><sup>19</sup></xref> (2) increased longevity and quality of life,<xref ref-type="bibr" rid="R19"><sup>19</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R22"><sup>22</sup></xref> (3) prevented high-fat-diet obesity,<xref ref-type="bibr" rid="R21"><sup>21</sup></xref> (4) altered systemic lupus erythematosus,<xref ref-type="bibr" rid="R22"><sup>22</sup></xref> (5) completely prevented development of mammary tumors of unknown etiology<xref ref-type="bibr" rid="R23"><sup>23</sup></xref> and (6) slowed progression of spontaneous or cigarette-smoke-induced liver cancers,<xref ref-type="bibr" rid="R19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R20"><sup>20</sup></xref> virally caused mammary tumors<xref ref-type="bibr" rid="R23"><sup>23</sup></xref> and leukemia (Click RE, in preparation). Some of these diseases have also been found to be altered by organosulfur compounds/derivatives derived from Allium and Brassica foods; the most extensively investigated are processes associated with tumorigenesis&#x2014;anticarcinogenic and apoptosis induction.<xref ref-type="bibr" rid="R24"><sup>24</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R26"><sup>26</sup></xref></p>
    <p>Of all the processes altered by 2-Me, the finding that 2-Me altered leukemia progression in AKR/Cum mice&#x2014;a strain that naturally harbors murine leukemia virus (MuLV) and at least four ecotropic, endogenous MuLV proviral DNA sequences<xref ref-type="bibr" rid="R27"><sup>27</sup></xref>&#x2014;was instrumental in why the protocol reported herein was tested in cattle. An adult, four-year-old multiparous dairy cow (#16) was found positive (sero-specific ELISA OD of 3.85 determined by the Univ Minn Vet Diagnostic Lab) for bovine leukemia virus (BLV). Cattle infected with this virus may develop lymphomas/leukemia;<xref ref-type="bibr" rid="R28"><sup>28</sup></xref> however, the incidence of disease is quite low relative to the number of positive animals in any given herd, likely because dairy cows in general are not productive much beyond 5&#x2013;6 y of age. Twenty-two months after #16 tested BLV positive, clinical symptoms indicative of lymphoma developed (lack of appetite, weight loss and enlarged fore-udder lymph nodes). In addition, although not having pipestream diarrhea, her feces were a bit loose, a symptom not typical of BLV infection. It should be pointed out that these symptoms are in general characteristic signs of early, clinical Johne disease. However, a diagnosis of Johne disease was considered unlikely because she had tested MAP negative<xref ref-type="bibr" rid="R29"><sup>29</sup></xref> multiple times over the prior two years. Based on the presumptuous diagnosis of BLV-induced leukosis and since there was/are no effective treatments for BLV disease in cattle, she was considered an ideal, non-rodent candidate to assess the safety and efficacy of the murine, 2-Me-leukemia protocol. Therefore, she was started on a once daily, feed additive regimen of 1.38 mg/kg body weight 2-Me, a dose slightly lower than the lowest effective dose for mice.<xref ref-type="bibr" rid="R21"><sup>21</sup></xref> After treatment was initiated, both fecal consistency and appetite returned to normal (reduced GI pain?) and both remained normal up until the day she succumbed. During this &#x201C;beneficial&#x201D; four-month interval, she unexpectedly continued to lose weight, which is not characteristic for BLV-caused leukosis, nor for the Dietzia probiotic reversal of Johne disease symptoms. This, plus the earlier pretreatment, atypical fecal consistency, indicated that retesting for MAP should once again be done. Surprisingly, this time she tested serologically positive by ELISA (an OD value of 2.4), but was serologically negative for AGID (a serological test that defines a more advanced disease than an ELISA<xref ref-type="bibr" rid="R29"><sup>29</sup></xref>) and negative for fecal MAP shedding, all determined by Allied Monitor, Inc.<xref ref-type="bibr" rid="R29"><sup>29</sup></xref> Three weeks after serum and feces were submitted for testing, she succumbed with Johne disease; anticipated because of the continued weight loss, but still not understood since treatment curtailed diarrhea and reduced GI pain sufficiently to return appetite to normal. This is striking because neither of these symptoms ever reversed in over 60 end-stage, non-treated or unsuccessfully treated animals that succumbed from Johne disease.<xref ref-type="bibr" rid="R6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R7"><sup>7</sup></xref> The results do suggest that 2-Me &#x201C;normalized&#x201D; the gastrointestinal tract in some manner, a result that may have value for IBD patients. Interestingly, a similar phenomenon&#x2014;decreased macroscopic and microscopic colonic damage&#x2014;was found for experimentally-induced colitis in rats by dietary methylsulfonylmethane,<xref ref-type="bibr" rid="R30"><sup>30</sup></xref> an organosulfur molecule with a chemical structure such that it likely functions via a mechanism similar to that postulated for 2-Me; i.e., generation of sulphane sulfur.<xref ref-type="bibr" rid="R31"><sup>31</sup></xref></p>
    <p>In conclusion, treatment of a cow with early signs of clinical Johne disease (plus two cows with BLV-induced leucosis that were negative for Johne disease; manuscript in preparation) with 2-Me was safe, just as found in rodents, and it had ameliorative effects for symptoms of a bovine intestinal bowel disease. The findings raise two intriguing questions: By what mechanism does intestinal &#x201C;well-being&#x201D; occur and would IBD patients, if treated with either food or xenobiotic organosulfurs, have a similar health-related quality of life benefit?</p>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>A special thanks to Dr Craig Van Kampen for editorial review. This work was supported by the National Institutes of Health (R01AI019643) prior to retirement from the University of Minnesota, Minneapolis, MN. NIH and Dr Van Kampen had no involvement in the study design, collection, analysis and interpretation of data, conclusions derived and decision to submit the manuscript for publication.</p>
    </ack>
    <fn-group>
      <fn fn-type="other">
        <p>Previously published online: <ext-link ext-link-type="uri" xlink:href="http://www.landesbioscience.com/journals/virulence/article/22090/">www.landesbioscience.com/journals/virulence/article/22090</ext-link></p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clarke</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>The pathology and pathogenesis of paratuberculosis in ruminants and other species</article-title>
          <source>J Comp Pathol</source>
          <year>1997</year>
          <volume>116</volume>
          <fpage>217</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="doi">10.1016/S0021-9975(97)80001-1</pub-id>
          <pub-id pub-id-type="pmid">9147244</pub-id>
        </element-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chiodini</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Van Kruiningen</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Merkal</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Ruminant paratuberculosis (Johne&#x2019;s disease): the current status and future prospects</article-title>
          <source>Cornell Vet</source>
          <year>1984</year>
          <volume>74</volume>
          <fpage>218</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="pmid">6375961</pub-id>
        </element-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chiodini</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Crohn&#x2019;s disease and the mycobacterioses: a review and comparison of two disease entities</article-title>
          <source>Clin Microbiol Rev</source>
          <year>1989</year>
          <volume>2</volume>
          <fpage>90</fpage>
          <lpage>117</lpage>
          <pub-id pub-id-type="pmid">2644025</pub-id>
        </element-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scanu</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Bull</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Cannas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sanderson</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Sechi</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Dettori</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn&#x2019;s disease and Johne&#x2019;s disease: common neural and immune pathogenicities</article-title>
          <source>J Clin Microbiol</source>
          <year>2007</year>
          <volume>45</volume>
          <fpage>3883</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.1128/JCM.01371-07</pub-id>
          <pub-id pub-id-type="pmid">17913930</pub-id>
        </element-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Click</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>A 60-day probiotic protocol with <italic>Dietzia</italic> subsp. <italic>C79793-74</italic> prevents development of Johne&#x2019;s disease parameters after in utero and/or neonatal MAP infection</article-title>
          <source>Virulence</source>
          <year>2011</year>
          <volume>2</volume>
          <fpage>337</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="doi">10.4161/viru.2.4.16137</pub-id>
          <pub-id pub-id-type="pmid">21701254</pub-id>
        </element-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Click</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Van Kampen</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>Assessment of <italic>Dietzia</italic> subsp. <italic>C79793-74</italic> for treatment of cattle with evidence of paratuberculosis</article-title>
          <source>Virulence</source>
          <year>2010</year>
          <volume>1</volume>
          <fpage>145</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="doi">10.4161/viru.1.3.10897</pub-id>
          <pub-id pub-id-type="pmid">21178433</pub-id>
        </element-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Click</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Successful treatment of asymptomatic or clinically terminal bovine <italic>Mycobacterium avium</italic> subspecies <italic>paratuberculosis</italic> infection (Johne&#x2019;s disease) with the bacterium Dietzia used as a probiotic alone or in combination with dexamethasone: Adaption to chronic human diarrheal diseases</article-title>
          <source>Virulence</source>
          <year>2011</year>
          <volume>2</volume>
          <fpage>131</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="doi">10.4161/viru.2.2.15647</pub-id>
          <pub-id pub-id-type="pmid">21460639</pub-id>
        </element-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whittington</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Windsor</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>In utero infection of cattle with <italic>Mycobacterium avium</italic> subsp. <italic>paratuberculosis</italic>: a critical review and meta-analysis</article-title>
          <source>Vet J</source>
          <year>2009</year>
          <volume>179</volume>
          <fpage>60</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tvjl.2007.08.023</pub-id>
          <pub-id pub-id-type="pmid">17928247</pub-id>
        </element-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feller</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Huwiler</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Stephan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Altpeter</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Shang</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Furrer</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>Mycobacterium avium</italic> subspecies <italic>paratuberculosis</italic> and Crohn&#x2019;s disease: a systematic review and meta-analysis</article-title>
          <source>Lancet Infect Dis</source>
          <year>2007</year>
          <volume>7</volume>
          <fpage>607</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1016/S1473-3099(07)70211-6</pub-id>
          <pub-id pub-id-type="pmid">17714674</pub-id>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chamberlin</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Naser</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Integrating theories of the etiology of Crohn&#x2019;s disease. On the etiology of Crohn&#x2019;s disease: questioning the hypotheses</article-title>
          <source>Med Sci Monit</source>
          <year>2006</year>
          <volume>12</volume>
          <fpage>RA27</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="pmid">16449960</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Behr</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Kapur</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>The evidence for <italic>Mycobacterium paratuberculosis</italic> in Crohn&#x2019;s disease</article-title>
          <source>Curr Opin Gastroenterol</source>
          <year>2008</year>
          <volume>24</volume>
          <fpage>17</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1097/MOG.0b013e3282f1dcc4</pub-id>
          <pub-id pub-id-type="pmid">18043227</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hermon-Taylor</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title><italic>Mycobacterium avium</italic> subspecies <italic>paratuberculosis</italic>, Crohn&#x2019;s disease and the Doomsday scenario</article-title>
          <source>Gut Pathog</source>
          <year>2009</year>
          <volume>1</volume>
          <fpage>15</fpage>
          <pub-id pub-id-type="doi">10.1186/1757-4749-1-15</pub-id>
          <pub-id pub-id-type="pmid">19602288</pub-id>
        </element-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pierce</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
          <article-title>Ulcerative colitis and Crohn&#x2019;s disease: is <italic>Mycobacterium avium</italic> subspecies <italic>paratuberculosis</italic> the common villain?</article-title>
          <source>Gut Pathog</source>
          <year>2010</year>
          <volume>2</volume>
          <fpage>21</fpage>
          <pub-id pub-id-type="doi">10.1186/1757-4749-2-21</pub-id>
          <pub-id pub-id-type="pmid">21167058</pub-id>
        </element-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Click</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Benck</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Alter</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Enhancement of antibody synthesis in vitro by mercaptoethanol</article-title>
          <source>Cell Immunol</source>
          <year>1972</year>
          <volume>3</volume>
          <fpage>156</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1016/0008-8749(72)90237-7</pub-id>
          <pub-id pub-id-type="pmid">5061825</pub-id>
        </element-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Click</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Benck</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Alter</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Immune responses in vitro. I. Culture conditions for antibody synthesis</article-title>
          <source>Cell Immunol</source>
          <year>1972</year>
          <volume>3</volume>
          <fpage>264</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1016/0008-8749(72)90165-7</pub-id>
          <pub-id pub-id-type="pmid">4551691</pub-id>
        </element-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heber-Katz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Click</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Immune responses in vitro. V. Role of mercaptoethanol in the mixed-leukocyte reaction</article-title>
          <source>Cell Immunol</source>
          <year>1972</year>
          <volume>5</volume>
          <fpage>410</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1016/0008-8749(72)90067-6</pub-id>
          <pub-id pub-id-type="pmid">4645593</pub-id>
        </element-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peck</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Click</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Immune responses in vitro. 3. Enhancement of the mouse mixed lymphocyte interaction by isologous and homologous sera</article-title>
          <source>Eur J Immunol</source>
          <year>1973</year>
          <volume>3</volume>
          <fpage>385</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="doi">10.1002/eji.1830030703</pub-id>
          <pub-id pub-id-type="pmid">4271347</pub-id>
        </element-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Stosic-Grujicic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Perkins</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Strehler</surname>
              <given-names>BL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Restoration of impaired immune functions in aging animals. VI. Differential potentiating effect of 2-mercaptoethanol on young and old murine spleen cells</article-title>
          <source>Int J Immunopharmacol</source>
          <year>1982</year>
          <volume>4</volume>
          <fpage>429</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="doi">10.1016/0192-0561(82)90017-0</pub-id>
          <pub-id pub-id-type="pmid">6982245</pub-id>
        </element-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heidrick</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Hendricks</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>DE</given-names>
            </name>
          </person-group>
          <article-title>Effect of dietary 2-mercaptoethanol on the life span, immune system, tumor incidence and lipid peroxidation damage in spleen lymphocytes of aging BC3F1 mice</article-title>
          <source>Mech Ageing Dev</source>
          <year>1984</year>
          <volume>27</volume>
          <fpage>341</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="doi">10.1016/0047-6374(84)90057-5</pub-id>
          <pub-id pub-id-type="pmid">6334792</pub-id>
        </element-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beregi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Regius</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Rajczy</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Boross</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>P&#xE9;nzes</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Effect of cigarette smoke and 2-mercaptoethanol administration on age-related alterations and immunological parameters</article-title>
          <source>Gerontology</source>
          <year>1991</year>
          <volume>37</volume>
          <fpage>326</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="doi">10.1159/000213280</pub-id>
          <pub-id pub-id-type="pmid">1662659</pub-id>
        </element-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Click</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Obesity, longevity, quality of life: alteration by dietary 2-mercaptoethanol</article-title>
          <source>Virulence</source>
          <year>2010</year>
          <volume>1</volume>
          <fpage>509</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="doi">10.4161/viru.1.6.13803</pub-id>
          <pub-id pub-id-type="pmid">21178502</pub-id>
        </element-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Click</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Longevity of SLE-prone mice increased by dietary 2-mercaptoethanol via a mechanism imprinted within the first 28 days of life</article-title>
          <source>Virulence</source>
          <year>2010</year>
          <volume>1</volume>
          <fpage>516</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="doi">10.4161/viru.1.6.13805</pub-id>
          <pub-id pub-id-type="pmid">21178504</pub-id>
        </element-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Click</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Dietary mercaptoethanol prevents or delays spontaneous murine mammary tumorigenesis</article-title>
          <comment>Submitted</comment>
        </element-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Milner</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis</article-title>
          <source>Adv Exp Med Biol</source>
          <year>2001</year>
          <volume>492</volume>
          <fpage>69</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="doi">10.1007/978-1-4615-1283-7_7</pub-id>
          <pub-id pub-id-type="pmid">11480676</pub-id>
        </element-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El-Bayoumy</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sinha</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pinto</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Rivlin</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Cancer chemoprevention by garlic and garlic-containing sulfur and selenium compounds</article-title>
          <source>J Nutr</source>
          <year>2006</year>
          <volume>136</volume>
          <issue>Suppl</issue>
          <fpage>864S</fpage>
          <lpage>9S</lpage>
          <pub-id pub-id-type="pmid">16484582</pub-id>
        </element-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cooper</surname>
              <given-names>AJL</given-names>
            </name>
            <name>
              <surname>Krasnikov</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Niatsetskaya</surname>
              <given-names>ZV</given-names>
            </name>
            <name>
              <surname>Pinto</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Callery</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Villar</surname>
              <given-names>MT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cysteine S-conjugate &#x3B2;-lyases: important roles in the metabolism of naturally occurring sulfur and selenium-containing compounds, xenobiotics and anticancer agents</article-title>
          <source>Amino Acids</source>
          <year>2011</year>
          <volume>41</volume>
          <fpage>7</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="doi">10.1007/s00726-010-0552-0</pub-id>
          <pub-id pub-id-type="pmid">20306345</pub-id>
        </element-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buckler</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Staal</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Rowe</surname>
              <given-names>WP</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Variation in the number of copies and in the genomic organization of ecotropic murine leukemia virus proviral sequences in sublines of AKR mice</article-title>
          <source>J Virol</source>
          <year>1982</year>
          <volume>43</volume>
          <fpage>629</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">6287036</pub-id>
        </element-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <mixed-citation publication-type="web">Kirk JH. Bovine Leukemia UC Davis Veterinary Medicine Extension. <comment><ext-link ext-link-type="uri" xlink:href="http://www.vetmed.ucdavis.edu/vetext/INF-DA/INF-DA_BovineLeukemia.html">www.vetmed.ucdavis.edu/vetext/INF-DA/INF-DA_BovineLeukemia.html</ext-link></comment></mixed-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Click</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Van Kampen</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>Comparison of ante-mortem assays to assess progression/regression of paratuberculosis in individual dairy animals</article-title>
          <source>Virulence</source>
          <year>2010</year>
          <volume>1</volume>
          <fpage>134</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="doi">10.4161/viru.1.3.10896</pub-id>
          <pub-id pub-id-type="pmid">21178432</pub-id>
        </element-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amirshahrokhi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bohlooli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chinifroush</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>The effect of methylsulfonylmethane on the experimental colitis in the rat</article-title>
          <source>Toxicol Appl Pharmacol</source>
          <year>2011</year>
          <volume>253</volume>
          <fpage>197</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="doi">10.1016/j.taap.2011.03.017</pub-id>
          <pub-id pub-id-type="pmid">21463646</pub-id>
        </element-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toohey</surname>
              <given-names>JI</given-names>
            </name>
          </person-group>
          <article-title>Sulphane sulphur in biological systems: a possible regulatory role</article-title>
          <source>Biochem J</source>
          <year>1989</year>
          <volume>264</volume>
          <fpage>625</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="pmid">2695062</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
